Form 4: Guardant Health Director Vests 3,167 Shares

Guardant Health Director Roberto Mignone acquired 3,167 shares of common stock through the vesting of restricted stock units.

Summary

• Roberto Mignone, a Director of Guardant Health, Inc. (GH), reported a change in beneficial ownership.
• On October 21, 2025, Mignone acquired 3,167 shares of Guardant Health Common Stock.
• These shares were acquired through the vesting of Restricted Stock Units (RSUs) at a price of $0 per share.
• Following this transaction, Mignone directly beneficially owns 3,167 shares of Common Stock.
• The RSUs were granted on November 8, 2024, with 25% vesting on October 21, 2025, which is the one-year anniversary of October 21, 2024.
• After the vesting and conversion of 3,167 RSUs, Mignone holds 9,504 remaining derivative securities (Restricted Stock Units).

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-scheduled vesting of restricted stock units for a director, which is a neutral event but slightly positive as it increases insider ownership and aligns interests with shareholders.

Positives

• A director's acquisition of common stock, even through vesting, aligns their interests with those of shareholders.
• The long-term vesting schedule (four years) for the RSUs indicates a commitment to the company's sustained performance.

Future Outlook

The remaining 75% of the Restricted Stock Units will vest monthly over the three-year period following October 21, 2025.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholders through direct stock ownership.

Next Steps

• Future monthly vesting of the remaining 75% of the Restricted Stock Units over the next three years.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled vesting of restricted stock units for a director. It does not contain any new material information regarding the company's financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. While it slightly increases insider ownership, this is a standard compensation event and not indicative of a significant shift in company fundamentals or valuation.

Keywords

Guardant Health, GH, Roberto Mignone, Director, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Common Stock, Beneficial Ownership